American Journal of Cardiology
Volume 102, Issue 5 , Pages 546-551 , 1 September 2008

Impact of Perioperative Myocardial Infarction on Angiographic and Clinical Outcomes Following Coronary Artery Bypass Grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)

  • James M. Yau, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • ,
  • John H. Alexander, MD, MHS

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: 919-668-8955; Fax: 919-668-7085
    • ,
  • Gail Hafley, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Kenneth W. Mahaffey, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Michael J. Mack, MD

      Affiliations

    • Cardiopulmonary Research Science & Technology Institute, Dallas, Texas
    • ,
  • Nicholas Kouchoukos, MD

      Affiliations

    • Missouri Baptist Medical Center, St. Louis, Missouri
    • ,
  • Abhinav Goyal, MD, MHS

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • C. Michael Gibson, MD

      Affiliations

    • PERFUSE Angiographic Laboratory, Boston, Massachusetts
    • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • T. Bruce Ferguson, MD

      Affiliations

    • East Carolina State University, Greenville, North Carolina
    • ,
  • PREVENT IV Investigators

Received 11 February 2008 ,Revised 17 April 2008 ,Accepted 17 April 2008.

References 

  1. Greaves SC, Rutherford JD, Aranki SF, Cohn LH, Couper GS, Adams DH, et al. Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J. 1996;132:572–578
  2. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002;39:1518–1523
  3. Namay DL, Hammermeister KE, Zia MS, DeRouen TA, Dodge HT, Namay K. Effect of perioperative myocardial infarction on later survival on patients undergoing coronary artery bypass surgery. Circulation. 1982;65:1066–1071
  4. Chaitman BR, Alderman EL, Sheffield LT, Tong T, Fisher L, Mock MB, et al Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation. 1983;67:302–309
  5. Miller DC, Sinson EB, Oyer PE, Jamieson SW, Mitchell RS, Reitz BA, et al. Discriminant analysis of the changing risks of coronary artery operations: 1971–1979. J Thorac Cardiovasc Surg. 1983;85:197–213
  6. Iyer VS, Russell WJ, Leppard P, Craddock D. Mortality and myocardial infarction after coronary artery surgery. Med J Aust. 1993;159:166–170
  7. Olthof H, Middelhof C, Meijne NG, Fiolet JW, Becker AE, Lie KI. The definition of myocardial infarction during aortocoronary bypass surgery. Am Heart J. 1983;106:631–637
  8. Burns RJ, Gladstone PJ, Tremblay PC, Feindel CM, Salter CM, Salter DR, et al. Myocardial infarction determined by technetium 99m pyrophosphate single-photon tomography complicating elective coronary artery bypass grafting for angina pectoris. Am J Cardiol. 1989;63:1429–1434
  9. Force T, Hibberd P, Weeks G, Kemper AJ, Bloomfield P, Tow D, et al. Perioperative myocardial infarction after coronary artery bypass surgery (Clinical significance and approach to risk stratification). Circulation. 1990;82:903–912
  10. Gray RJ, Matloff JM, Conklin CM, Ganz W, Charuzi Y, Wolfstein R, et al. Perioperative myocardial infarction: late clinical course after coronary artery bypass surgery. Circulation. 1982;66:1185–1189
  11. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al ACC key elements and data definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndrome Writing Committee). J Am Coll Cardiol. 2001;38:2114–2130
  12. Alexander JH, Ferguson TB, Joseph DM, Mack MJ, Wolf RK, Gibson CM, et al The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J. 2005;150:643–649
  13. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446–2454
  14. Järvinen O, Julkunen J, Saarinen T, Laurikka J, Huhtala H, Tarkka MR. Perioperative myocardial infarction has negative impact on health-related quality of life following coronary bypass graft surgery. Eur J Cardiothorac Surg. 2004;26:621–627
  15. Espinoza J, Lipski J, Litwak R, Donoso E, Dack S. New Q waves after coronary artery bypass surgery for angina pectoris. Am J Cardiol. 1974;33:221–224
  16. Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting (The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group). J Thorac Cardiovasc Surg. 1998;116:460–467
  17. Kennedy JW, Kaiser GC, Fisher LD, Maynard C, Fritz JK, Myers W, et al. Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). J Thorac Cardiovasc Surg. 1980;80:876–887
  18. Sergeant PT, Blackstone EH, Meyns BP. Does arterial revascularization decrease the risk of infarction after coronary artery bypass grafting?. Ann Thorac Surg. 1998;66:1–10
  19. Steuer J, Horte LG, Lindahl B, Stahle E. Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting. Eur Heart J. 2002;23:1219–1227
  20. Klatte K, Chaitman R, Theroux P, Gavard JA, Stocke K, Boyce S, et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatinine kinase-myocardial band isoenzyme release (Results from the GUARDIAN Trial). J Am Coll Cardiol. 2001;38:1070–1077
  21. Silber JH, Rosenbaum PR, Schwartz JS, Ross RN, Williams SV. Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery. JAMA. 1995;274:317–323
  22. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol. 2002;40:1961–1967
  23. Ranucci M, Frigiola A, Menicanti L, Cazzaniga A, Soro G, Isgrò G. Risk factors for fatal myocardial infarction after coronary bypass graft surgery. Eur J Anaesthesiol. 2001;18:322–329
  24. Yokoyama Y, Chaitman BR, Hardison RM, Guo P, Krone P, Stocke K, et al. Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients. Am J Cardiol. 2000;86:819–824
  25. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W, et al Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapy Study (ARTS). Circulation. 2001;104:2689–2693
  26. Birjiniuk V. Patient outcomes in the assessment of myocardial injury following cardiac surgery. Ann Thorac Surg. 2001;72(suppl):S2208–S2212
  27. Ramsay J, Shernan S, Fitch J, Finnegan P, Todaro T, Filloon T, et al. Increased creatinine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J Thorac Cardiovasc Surg. 2005;129:300–306
  28. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, et al Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241–251
  29. Thygesen K, Alpert JS, White HD Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525–2538

 This work was supported by the Duke Clinical Research Institute, Durham, North Carolina. The PREVENT-IV Trial was supported by Corgentech Inc., South San Francisco, California. Dr. Alexander, G. Hafley, Dr. Mahaffey, Dr. Mack, Dr. Kouchoukos, Dr. Goyal, Dr. Peterson, Dr. Gibson, Dr. Califf, Dr. Harrington, and Dr. Ferguson received research funding from Corgentech Inc. for their participation in PREVENT IV.

PII: S0002-9149(08)00748-0

doi: 10.1016/j.amjcard.2008.04.069

American Journal of Cardiology
Volume 102, Issue 5 , Pages 546-551 , 1 September 2008

Article Tools

* Image Usage & Resolution